Hair loss drug spironolactone may be safe for use in breast cancer survivors

Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University (GW) Department of Dermatology. The study, published in the Journal of the American Academy of Dermatology, found that the drug may be safe for use in treating breast cancer survivors with female pattern hair loss. […]

Continue Reading

China and India agree to disengage troops on contested Himalayan border

In June, tensions erupted into a frontier clash in which 20 Indian soldiers were killed and China suffered an unspecified number of casualties. Chinese State Councilor Wang Yi and Indian Foreign Minister S. Jaishankar met in Moscow on Thursday and reached a five-point consensus, including agreements that troops from both sides should quickly disengage and […]

Continue Reading